These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10694614)

  • 1. Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease.
    Starnes SL; Duncan BW; Kneebone JM; Rosenthal GL; Jones TK; Grifka RG; Cecchin F; Owens DJ; Fearneyhough C; Lupinetti FM
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):534-9. PubMed ID: 10694614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor in children with congenital heart disease.
    Ootaki Y; Yamaguchi M; Yoshimura N; Oka S; Yoshida M; Hasegawa T
    Ann Thorac Surg; 2003 May; 75(5):1523-6. PubMed ID: 12735573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic growth factors in patients with cyanotic congenital heart disease and in normal children.
    Himeno W
    Kurume Med J; 2001; 48(2):111-6. PubMed ID: 11501491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor in children with cyanotic and acyanotic and congenital heart disease.
    Baghdady Y; Hussein Y; Shehata M
    Arch Med Sci; 2010 Apr; 6(2):221-5. PubMed ID: 22371751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between vascular endothelial growth factor and leptin in children with cyanotic congenital heart disease.
    Aydin HI; Yozgat Y; Demirkaya E; Olgun A; Okutan V; Lenk MK; Ozcan O
    Turk J Pediatr; 2007; 49(4):360-4. PubMed ID: 18246735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and pulmonary vascular endothelial growth factor/receptors and haemodynamic measurements in cyanotic congenital heart disease with decreased pulmonary blood flow.
    Tolunay I; Tunaoglu S; Akyürek N; Halid V; Olgunturk R; Kula S
    Cardiol Young; 2011 Dec; 21(6):608-15. PubMed ID: 21774842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
    Waltham M; Burnand KG; Collins M; Smith A
    J Vasc Surg; 2000 Nov; 32(5):988-96. PubMed ID: 11054231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor and its soluble receptor in infants with congenital cardiac disease.
    Pohl-Schickinger A; Koehne P; Schmitz T; Schmitt KR; Hübler M; Redlin M; Berger F; Stiller B
    Cardiol Young; 2010 Oct; 20(5):505-8. PubMed ID: 20470449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
    Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
    Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
    Dirix LY; Vermeulen PB; Pawinski A; Prové A; Benoy I; De Pooter C; Martin M; Van Oosterom AT
    Br J Cancer; 1997; 76(2):238-43. PubMed ID: 9231925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of angiogenesis stimulators in children with solid malignancies.
    Pavlakovic H; Von Schütz V; Rössler J; Koscielniak E; Havers W; Schweigerer L
    Int J Cancer; 2001 Jun; 92(5):756-60. PubMed ID: 11340583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
    Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased angiogenic growth factor in cyanotic congenital heart disease.
    Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
    Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia.
    Bairey O; Zimra Y; Shaklai M; Rabizadeh E
    Br J Haematol; 2001 May; 113(2):400-6. PubMed ID: 11380405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of ghrelin, tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease.
    Afify MF; Mohamed GB; El-Maboud MA; Abdel-Latif EA
    J Trop Pediatr; 2009 Dec; 55(6):388-92. PubMed ID: 19491251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus.
    Malamitsi-Puchner A; Sarandakou A; Tziotis J; Dafogianni C; Bartsocas CS
    Pediatr Res; 1998 Dec; 44(6):873-5. PubMed ID: 9853920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia.
    Yetgin S; Yenicesu I; Cetin M; Tuncer M
    Leuk Lymphoma; 2001 Jun; 42(1-2):83-8. PubMed ID: 11699225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia.
    Molica S; Vitelli G; Levato D; Ricciotti A; Digiesi G
    Br J Cancer; 2002 Jan; 86(1):31-5. PubMed ID: 11857008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.